EDAP to Present at Jefferies Global Healthcare Conference in London
EDAP (Nasdaq: EDAP) will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025. Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings from 4:30–4:55 pm GMT at the Waldorf – Aldwych, Entresol Level.
A live webcast will be available on the conference webcast page and an archived replay will be accessible in the company’s Investors section.
EDAP (Nasdaq: EDAP) parteciperà alla Jefferies Global Healthcare Conference a Londra martedì 18 novembre 2025. Ryan Rhodes, Amministratore Delegato, è previsto tenere una presentazione e ospitare incontri individuali con gli investitori dalle 16:30–16:55 GMT presso Waldorf – Aldwych, Entresol Level.
Una trasmissione in diretta sarà disponibile sulla pagina webcast della conferenza e una replica archiviata sarà accessibile nella sezione Investitori dell'azienda.
EDAP (Nasdaq: EDAP) participará en la Jefferies Global Healthcare Conference en Londres el martes, 18 de noviembre de 2025. Ryan Rhodes, Director Ejecutivo, está previsto que realice una presentación y coordine reuniones individuales con inversores desde las 16:30–16:55 GMT en Waldorf – Aldwych, Entresol Level.
Una transmisión en directo estará disponible en la página web de la conferencia y una reproducción archivada estará accesible en la sección de Inversores de la empresa.
EDAP (나스닥: EDAP)은 런던에서 열리는 Jefferies Global Healthcare Conference에 2025년 11월 18일 화요일에 참석합니다. 최고경영자 Ryan Rhodes가 GMT 16:30–16:55 사이에 발표를 진행하고 Waldorf – Aldwych, Entresol Level에서 1대1 투자자 미팅을 주관할 예정입니다.
라이브 생방송은 컨퍼런스 웹캐스트 페이지에서 시청 가능하며, 회사의 투자자 섹션에서 보관된 재방송을 이용할 수 있습니다.
EDAP (Nasdaq: EDAP) participera à la Jefferies Global Healthcare Conference à Londres le mardi 18 novembre 2025. Ryan Rhodes, Chief Executive Officer, est prévu pour une présentation et pour des entretiens investisseurs individuels de 16h30–16h55 GMT au Waldorf – Aldwych, Entresol Level.
Une retransmission en direct sera disponible sur la page webcast de la conférence et une rediffusion sera accessible dans la section Investisseurs de l'entreprise.
EDAP (Nasdaq: EDAP) wird auf der Jefferies Global Healthcare Conference in London am Dienstag, 18. November 2025 auftreten. Ryan Rhodes, Chief Executive Officer, ist vorgesehen, eine Präsentation zu geben und 1-zu-1-Investorenmeetings von 16:30–16:55 GMT im Waldorf – Aldwych, Entresol Level, durchzuführen.
Eine Live-Übertragung wird auf der Konferenz-Webcast-Seite verfügbar sein und eine archivierte Wiedergabe wird im Bereich Investoren des Unternehmens zugänglich sein.
EDAP (ناسداك: EDAP) ستقدم في Jefferies Global Healthcare Conference في لندن يوم الثلاثاء 18 نوفمبر 2025. روهان رودس، الرئيس التنفيذي، من المقرر أن يقدم عرضاً ويستضيف اجتماعات فردية مع المستثمرين من 4:30–4:55 مساءً بتوقيت GMT في Waldorf – Aldwych، Entresol Level.
سيكون هناك بث مباشر متاح على صفحة البث الخاصة بالاجتماع وسيكون بإمكان الحضور الوصول إلى إعادة العرض المؤرشفة في قسم المستثمرين لدى الشركة.
- None.
- None.
EDAP to Present at Jefferies Global Healthcare Conference in London
Company to Present and Host 1x1 Investor Meetings on Tuesday, November 18th, 2025
AUSTIN, Texas, November 4, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and host 1x1 investor meetings at the upcoming Jefferies Global Healthcare Conference, which is being held November 18-20, 2025, in London, United Kingdom.
Date: Tuesday, November 18th
Presentation Time: 4:30-4:55 pm GMT
Format: Presentation and 1x1 investor meetings
Location: Waldorf – Aldwych, Entresol Level
Webcast: https://wsw.com/webcast/jeff332/edap/1817998
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
legal@focalone.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When is EDAP (Nasdaq: EDAP) presenting at the Jefferies Global Healthcare Conference in 2025?
Who will represent EDAP at the Jefferies Global Healthcare Conference on November 18, 2025?
How can investors watch EDAP's Jefferies conference presentation on November 18, 2025?
Where is EDAP presenting during the Jefferies Global Healthcare Conference in London?
Will EDAP host one-on-one investor meetings at the Jefferies Global Healthcare Conference?
What is the webcast URL for EDAP's Jefferies Global Healthcare Conference presentation?
